AAAAAA

   
Results: 1-8 |
Results: 8
PROGNOSTIC IMPACT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PA), PA INHIBITOR TYPE-1, AND TISSUE-TYPE PA ANTIGEN LEVELS IN NODE-NEGATIVE BREAST-CANCER - A PROSPECTIVE-STUDY ON MULTICENTER BASIS
Authors: KIM SJ SHIBA E KOBAYASHI T YAYOI E FURUKAWA J TAKATSUKA Y SHIN E KOYAMA H INAJI H TAKAI SI
Citation: Sj. Kim et al., PROGNOSTIC IMPACT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PA), PA INHIBITOR TYPE-1, AND TISSUE-TYPE PA ANTIGEN LEVELS IN NODE-NEGATIVE BREAST-CANCER - A PROSPECTIVE-STUDY ON MULTICENTER BASIS, Clinical cancer research, 4(1), 1998, pp. 177-182
PROGNOSTIC IMPACT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PA), PA INHIBITOR TYPE-1, AND TISSUE-TYPE PA ANTIGEN LEVELS IN NODE-NEGATIVE BREAST-CANCER - A PROSPECTIVE-STUDY ON MULTICENTER BASIS
Authors: KIM SJ SHIBA E KOBAYASHI T YAYOI E FURUKAWA J TAKATSUKA Y SHIN E KOYAMA H INAJI H TAKAI SI
Citation: Sj. Kim et al., PROGNOSTIC IMPACT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PA), PA INHIBITOR TYPE-1, AND TISSUE-TYPE PA ANTIGEN LEVELS IN NODE-NEGATIVE BREAST-CANCER - A PROSPECTIVE-STUDY ON MULTICENTER BASIS, Clinical cancer research, 4(1), 1998, pp. 177-182
MECHANISM OF GROWTH-INHIBITION BY CALPAIN INHIBITOR IN MCF-7 CELLS
Authors: SHIBA E KIM SJ KAMBAYASHI JI KAWAMURA I LACEY E MANDA T SHIMOMURA K TAGUCHI T TAKAI SI
Citation: E. Shiba et al., MECHANISM OF GROWTH-INHIBITION BY CALPAIN INHIBITOR IN MCF-7 CELLS, Anticancer research, 17(3C), 1997, pp. 1919-1923
THROMBOMODULIN IS A NEW BIOLOGICAL AND PROGNOSTIC MARKER FOR BREAST-CANCER - AN IMMUNOHISTOCHEMICAL STUDY
Authors: KIM SJ SHIBA E ISHII H INOUE T TAGUCHI T TANJI Y KIMOTO Y IZUKURA M TAKAI SI
Citation: Sj. Kim et al., THROMBOMODULIN IS A NEW BIOLOGICAL AND PROGNOSTIC MARKER FOR BREAST-CANCER - AN IMMUNOHISTOCHEMICAL STUDY, Anticancer research, 17(3C), 1997, pp. 2319-2323
UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR IS A NOVEL PROGNOSTIC FACTOR IN BREAST-CANCER
Authors: KIM SJ SHIBA E TAGUCHI T WATANABE T TANJI Y KIMOTO Y IZUKURA M TAKAI SI
Citation: Sj. Kim et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR IS A NOVEL PROGNOSTIC FACTOR IN BREAST-CANCER, Anticancer research, 17(2B), 1997, pp. 1373-1378
THE RELATIONSHIP BETWEEN SPECIFIC RET PROTOONCOGENE MUTATIONS AND DISEASE PHENOTYPE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - INTERNATIONAL RET MUTATION CONSORTIUM ANALYSIS
Authors: ENG C CLAYTON D SCHUFFENECKER I LENOIR G COTE G GAGEL RF VANAMSTEL HKP LIPS CJM NISHISHO I TAKAI SI MARSH DJ ROBINSON BG FRANKRAUE K RAUE F XUE FY NOLL WW ROMEI C PACINI F FINK M NIEDERLE B ZEDENIUS J NORDENSKJOLD M KOMMINOTH P HENDY GN GHARIB H THIBODEAU SN LACROIX A FRILLING A PONDER BAJ MULLIGAN LM
Citation: C. Eng et al., THE RELATIONSHIP BETWEEN SPECIFIC RET PROTOONCOGENE MUTATIONS AND DISEASE PHENOTYPE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - INTERNATIONAL RET MUTATION CONSORTIUM ANALYSIS, JAMA, the journal of the American Medical Association, 276(19), 1996, pp. 1575-1579
FREQUENT LOSS OF HETEROZYGOSITY AT TELOMERIC LOCI ON 22Q IN SPORADIC COLORECTAL CANCERS
Authors: YANA I KURAHASHI H NAKAMORI S KAMEYAMA M NAKAMURA T TAKAMI M MORI T TAKAI SI NISHISHO I
Citation: I. Yana et al., FREQUENT LOSS OF HETEROZYGOSITY AT TELOMERIC LOCI ON 22Q IN SPORADIC COLORECTAL CANCERS, International journal of cancer, 60(2), 1995, pp. 174-177
DELETION MAPPING OF THE LONG ARM OF CHROMOSOME-22 IN HUMAN MENINGIOMAS
Authors: AKAGI K KURAHASHI H ARITA N HAYAKAWA T MONDEN M MORI T TAKAI SI NISHISHO I
Citation: K. Akagi et al., DELETION MAPPING OF THE LONG ARM OF CHROMOSOME-22 IN HUMAN MENINGIOMAS, International journal of cancer, 60(2), 1995, pp. 178-182
Risultati: 1-8 |